LV13630B - Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone - Google Patents

Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone Download PDF

Info

Publication number
LV13630B
LV13630B LVP-06-45A LV060045A LV13630B LV 13630 B LV13630 B LV 13630B LV 060045 A LV060045 A LV 060045A LV 13630 B LV13630 B LV 13630B
Authority
LV
Latvia
Prior art keywords
pyrrolidinone
phenyl
compound
carbamoylmethyl
phenotropil
Prior art date
Application number
LVP-06-45A
Other languages
English (en)
Latvian (lv)
Inventor
Grigorijs Veinbergs
Maksims Vorona
Maija Dambrova
Liga Zvejniece
Ligita Karina
Ivars Kalvins
Aleksandrs Cernobrovijs
Original Assignee
Olainfarm As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olainfarm As filed Critical Olainfarm As
Priority to LVP-06-45A priority Critical patent/LV13630B/en
Priority to DK07726915.7T priority patent/DK2013166T3/da
Priority to PT07726915T priority patent/PT2013166E/pt
Priority to CNA2007800177832A priority patent/CN101448786A/zh
Priority to DE602007005244T priority patent/DE602007005244D1/de
Priority to CA2647206A priority patent/CA2647206C/fr
Priority to GEAP200710934A priority patent/GEP20104915B/en
Priority to EA200801978A priority patent/EA014668B1/ru
Priority to ES07726915T priority patent/ES2342024T3/es
Priority to US12/226,332 priority patent/US9102615B2/en
Priority to AT07726915T priority patent/ATE460396T1/de
Priority to PCT/EP2007/052424 priority patent/WO2007104780A2/fr
Priority to UAA200812099A priority patent/UA96440C2/ru
Priority to SI200730253T priority patent/SI2013166T1/sl
Priority to EP07726915A priority patent/EP2013166B1/fr
Priority to EEP200800063A priority patent/EE05536B1/xx
Priority to PL07726915T priority patent/PL2013166T3/pl
Priority to MEP-2009-293A priority patent/ME01192B/fr
Publication of LV13630B publication Critical patent/LV13630B/en
Priority to LT2008075A priority patent/LT5589B/lt
Priority to HRP20090524AA priority patent/HRP20090524C1/hr
Priority to CY20101100506T priority patent/CY1110170T1/el
Priority to US14/688,633 priority patent/US9382203B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
LVP-06-45A 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone LV13630B (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
PCT/EP2007/052424 WO2007104780A2 (fr) 2006-03-16 2007-03-15 Procédé de préparation et d'utilisation de n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone pharmacologiquement actif
UAA200812099A UA96440C2 (ru) 2006-03-16 2007-03-15 Способ получения и применения фармакологически активного n-карбамоилметил-4-(r)-фенил-2-пирролидинона
PT07726915T PT2013166E (pt) 2006-03-16 2007-03-15 N-carbamoilmetilo-4(r)fenilo-2-pirrolidinona, processos de sua preparação e utilização farmacêutica
DE602007005244T DE602007005244D1 (de) 2006-03-16 2007-03-15 N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung
CA2647206A CA2647206C (fr) 2006-03-16 2007-03-15 N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinone, procede de preparation et usage pharmaceutique
GEAP200710934A GEP20104915B (en) 2006-03-16 2007-03-15 N-carbamoylmethyl-4-(r) – phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use
EA200801978A EA014668B1 (ru) 2006-03-16 2007-03-15 Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона
ES07726915T ES2342024T3 (es) 2006-03-16 2007-03-15 N-carbamoilmetil-4(r)-fenil-2-pirrolidinona, su procedimiento de prepaacion y uso farmaceutico.
SI200730253T SI2013166T1 (sl) 2006-03-16 2007-03-15 N-karbamoilmetil-4(r)-fenil-2-pirolidinon, postopek za njegovo pripravo in farmacevtska uporaba
AT07726915T ATE460396T1 (de) 2006-03-16 2007-03-15 N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung
DK07726915.7T DK2013166T3 (da) 2006-03-16 2007-03-15 N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidon, fremgangsmåde til fremstilling heraf og farmaceutisk anvendelse
CNA2007800177832A CN101448786A (zh) 2006-03-16 2007-03-15 N-氨基甲酰甲基-4(r)-苯基-2-吡咯烷酮的制备方法及药物用途
US12/226,332 US9102615B2 (en) 2006-03-16 2007-03-15 N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use
EP07726915A EP2013166B1 (fr) 2006-03-16 2007-03-15 N-carbamoylmethyl-4(r)phenyl-2-pyrrolidinone, procedes de preparation et utilisation pharmaceutique
EEP200800063A EE05536B1 (et) 2006-03-16 2007-03-15 N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine
PL07726915T PL2013166T3 (pl) 2006-03-16 2007-03-15 N-karbamoilometylo-4(R)-fenylo-2-pirolidynon, sposób jego wytwarzania i zastosowanie farmaceutyczne
MEP-2009-293A ME01192B (fr) 2006-03-16 2007-03-15 PROCÉDÉ DE PRÉPARATION ET D'UTILISATION DE N-CARBAMOYLMETHYL-4(<i>R</i>)-PHENYL-2-PYRROLIDINONE PHARMACOLOGIQUEMENT ACTIF
LT2008075A LT5589B (lt) 2006-03-16 2008-09-22 N-karbamoilmetil-4-(r)-fenil-2-pirolidinonas, jo gavimo būdas ir farmacinis panaudojimas
HRP20090524AA HRP20090524C1 (hr) 2006-03-16 2009-09-30 Metoda priprave i upotreba farmakološki aktivnog n-karbamoilmetil-4(r)-fenil-2-pirolidinona
CY20101100506T CY1110170T1 (el) 2006-03-16 2010-06-08 Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
US14/688,633 US9382203B2 (en) 2006-03-16 2015-04-16 N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone

Publications (1)

Publication Number Publication Date
LV13630B true LV13630B (en) 2007-12-20

Family

ID=38461010

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone

Country Status (21)

Country Link
US (2) US9102615B2 (fr)
EP (1) EP2013166B1 (fr)
CN (1) CN101448786A (fr)
AT (1) ATE460396T1 (fr)
CA (1) CA2647206C (fr)
CY (1) CY1110170T1 (fr)
DE (1) DE602007005244D1 (fr)
DK (1) DK2013166T3 (fr)
EA (1) EA014668B1 (fr)
EE (1) EE05536B1 (fr)
ES (1) ES2342024T3 (fr)
GE (1) GEP20104915B (fr)
HR (1) HRP20090524C1 (fr)
LT (1) LT5589B (fr)
LV (1) LV13630B (fr)
ME (1) ME01192B (fr)
PL (1) PL2013166T3 (fr)
PT (1) PT2013166E (fr)
SI (1) SI2013166T1 (fr)
UA (1) UA96440C2 (fr)
WO (1) WO2007104780A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV14346B (lv) * 2009-11-05 2011-07-20 Grindeks, A/S 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetam&imacr;da 4R,5S-enantiom&emacr;rs ar nootropo aktivit&amacr;ti
EP2694474A1 (fr) * 2011-03-11 2014-02-12 Grindeks Enantiomère 4r,5r du 2-(5-méthyl-2-oxo-4-phénylpyrrolidine-1-yl) acétamide à activité nootropique
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
CN104350063B (zh) 2012-05-08 2018-01-05 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
TW201408294A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療帕金森氏症之用除
TW201408293A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
LV15003B (lv) * 2013-10-22 2015-08-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
LV15015B (lv) 2013-12-13 2015-12-20 Olainfarm, A/S 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana
LV15016B (lv) * 2013-12-18 2016-01-20 Olainfarm, A/S N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas
EP2891491A1 (fr) 2014-01-03 2015-07-08 Merz Pharma GmbH & Co. KGaA Utilisation de (r) -phénylpiracétame pour le traitement de troubles du sommeil
LV15072B (lv) 2014-05-14 2016-09-20 Olainfarm, A/S Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
EP3127539A1 (fr) * 2015-08-03 2017-02-08 Latvian Institute Of Organic Synthesis Utilisation de 2- (5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl) -acétamide dans le traitement de crises d'épilepsie
WO2024049236A1 (fr) * 2022-08-31 2024-03-07 고려대학교 산학협력단 Dérivé de gamma lactame chiral ou sel pharmaceutiquement acceptable de celui-ci, et sa méthode de préparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
RU2232578C1 (ru) 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Вещество, обладающее антидепрессивной активностью
RU2289404C1 (ru) * 2005-04-06 2006-12-20 ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах

Also Published As

Publication number Publication date
EP2013166B1 (fr) 2010-03-10
LT2008075A (en) 2009-06-25
EA014668B1 (ru) 2010-12-30
DK2013166T3 (da) 2010-07-05
SI2013166T1 (sl) 2010-07-30
ME01192B (fr) 2012-12-20
ES2342024T3 (es) 2010-06-30
EE05536B1 (et) 2012-04-16
HRP20090524A2 (hr) 2009-12-31
US20150216846A1 (en) 2015-08-06
GEP20104915B (en) 2010-03-10
EP2013166A2 (fr) 2009-01-14
US20100022784A1 (en) 2010-01-28
EE200800063A (et) 2008-12-15
HRP20090524C1 (hr) 2017-03-10
CA2647206C (fr) 2011-09-27
UA96440C2 (ru) 2011-11-10
CY1110170T1 (el) 2015-01-14
US9382203B2 (en) 2016-07-05
ATE460396T1 (de) 2010-03-15
CA2647206A1 (fr) 2007-09-20
WO2007104780A2 (fr) 2007-09-20
HRPK20090524B3 (hr) 2012-12-31
LT5589B (lt) 2009-08-25
DE602007005244D1 (de) 2010-04-22
EA200801978A1 (ru) 2009-04-28
US9102615B2 (en) 2015-08-11
CN101448786A (zh) 2009-06-03
PT2013166E (pt) 2010-06-09
WO2007104780A3 (fr) 2007-11-29
PL2013166T3 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
LV13630B (en) Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
RU2140901C1 (ru) АНАЛОГИ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, СПОСОБ ЛЕЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
US8957226B2 (en) 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
González-Sabı́n et al. CAL-B-catalyzed resolution of some pharmacologically interesting β–substituted isopropylamines
Baures et al. Crystal structure, absolute configuration, and phosphodiesterase inhibitory activity of (+)-1-(4-bromobenzyl)-4-[(3-cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone
GEP20043236B (en) Asymmetric Synthesis of Pregabalin
ZA200501311B (en) Pyrrolidone derivatives as MAOB inhibitors
HRP20110762T1 (hr) Supstituirani n-fenilbipirolidinkarboksamidi i njihova upotreba u terapiji
IL160045A (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacture of levetiracetam and analogues
CN1292779A (zh) 用作－氧化氮合酶抑制剂的卤代脒基氨基酸衍生物
AU2006224774B2 (en) Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors
IL108969A (en) Transformed history of amyloxacoxibenzyl (aminopropionamide, their preparation and pharmaceutical preparations containing them
ATE289583T1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
HUP0301578A2 (hu) Szubsztituált nitrált katechinek, alkalmazásuk, valamint ilyen vegyületeket tartalmazó gyógyászati készítmények
JP2008508335A (ja) Ｍａｏｂインヒビターとしてのベンジルオキシ誘導体
JP7026852B2 (ja) チアジアゾール誘導体及びｇｌｓ１阻害剤としてのその使用
Wang et al. New synthesis of β-aryl-GABA drugs
WO2007104781A2 (fr) Procédé de fabrication du r-énantiomère de n-carbamoylmethyl-4-phenyl-2-pyrrolidone
LV14346B (lv) 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetam&amp;imacr;da 4R,5S-enantiom&amp;emacr;rs ar nootropo aktivit&amp;amacr;ti
CN110922354B (zh) 一种1-r-3-氟哌啶-4-羧酸的化学拆分制备方法及其产物
EP1861362A1 (fr) Procede de preparation de derives ether 4-pyrrolidinophenylbenzylique purs sur le plan enantiomerique
CN116162128A (zh) 一种抗病毒感染的核苷衍生物及其制备方法与用途
US20210355084A1 (en) N-substituted indoles and use as allosteric modulators of cannabinoid receptors
CHANG et al. New Synthesis of Β-Aryl-Gaba Drugs
SK1032001A3 (en) Alpha-amino acid phenyl ester derivatives